Introduction {#S0001}
============

Recently, a large body of evidence has highlighted the role of vitamin D in different physiopathological settings other than bone and calcium, including endothelial functions and blood pressure \[[@CIT0001], [@CIT0002]\]. In fact, cross-sectional analyses and prospective studies revealed that 25-hydroxy vitamin D (25-OHD) serum levels were inversely related to high cardiovascular risk \[[@CIT0003]--[@CIT0005]\] and calcium metabolism and the cardiovascular system may have an interaction \[[@CIT0006]\]. On the other hand, normalisation of 25-OHD level by exogenous supplementation is associated with a slight but significant improvement in blood pressure \[[@CIT0007]--[@CIT0010]\].

Beyond all this evidence, the final explanation of the vitamin D antihypertensive effect is yet not fully understood \[[@CIT0001]\]. Since vitamin D receptors are expressed in many tissues, it may have an effect on inflammation, cell proliferation and differentiation \[[@CIT0011]\], all factors that could influence vascular function and health. Preclinical studies and clinical reports showed an inverse association of vitamin D and endothelial function \[[@CIT0012], [@CIT0013]\]. Very recently, Harris *et al*. observed in a small group of African-American overweight patients that vitamin D~3~ supplementation may improve flow-mediated dilatation when compared to placebo \[[@CIT0014]\].

The relationship between vitamin D and endothelial dysfunction is still not clear. Studies with non-invasive methods to measure endothelial function generally use FMD (flow-mediated dilatation) of large arteries, asymmetric dimethyl arginine measurements or augmentation index calculations from pulse wave velocity \[[@CIT0012], [@CIT0015], [@CIT0016]\].

Reactive hyperaemia index (RHI) measurements taken with a pulse amplitude tonometry (PAT) device were found to be correlated with adverse cardiac events in different studies \[[@CIT0017], [@CIT0018]\], but there has not been any study examining the relationship between vitamin D levels and RHI measurements with this tonometric method.

In this context, the aim of our study was to evaluate the relationship between endothelial function and vitamin D serum level in a cohort of normotensive, non-smoker, normolipidaemic and normoglycaemic women, evaluated by the tonometric measurement of the RHI.

Material and methods {#S0002}
====================

Patients {#S20007}
--------

For this study, we consecutively enrolled 56 normotensive, non-smoker, normolipidaemic and normoglycaemic women, 23 with 25-OHD levels\>20 µg/l (normal range) and 33 with values lower than 20 µg/l (low 25-OHD group) \[[@CIT0019]\]. Patients using vitamin or calcium preparations, or affected by known osteoporosis, renal or hepatic disease were excluded from the study.

Anthropometric parameters were recorded and body mass index (BMI) was calculated as weight in kilograms divided by square of height in metres (kg/m^2^). Blood pressure was measured by standard sphygmomanometer and recorded from both arms while the patients were in a sitting position. According to the current guidelines \[[@CIT0020]\] the measurements were repeated 3 times with minimum 5-min intervals and the mean value was recorded.

Informed consent was obtained from each patient, and the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in *a priori* approval by the university\'s Human Research Committee.

Endothelial function measurement {#S20008}
--------------------------------

Pulse amplitude tonometry (PAT) is a technique for non-invasive endothelial function assessment from changes in vascular tone using plethysmographic bio-sensors placed on the fingertips. \[[@CIT0021]\]. It is based on non-invasive peripheral arterial tone signal technology. Standard 5-min occlusion of the brachial artery by a cuff creates a downstream hyperaemic response and changes in arterial tone are measured and the index is calculated automatically by the software of the device. A RHI score of 1.67 and below correlates with endothelial dysfunction \[[@CIT0022]\].

In our study, digital pulse amplitude was measured by Endo-PAT 2000™ (Itamar, Endothelial Function Assessment Device, Caeserea, Israel) used with the EndoPAT software system. A cardiologist who was blind to vitamin D results made the measurements. The test took nearly 15-20 min and was performed in a calm and quiet room at 22°C temperature, at rest. Each patient received an explanation about the procedure before the test and gave informed consent for the study. The measurement was performed on the lying patient with pre- and post-occlusion measurements of RHI by digital sensors placed on each index finger, at 5-min intervals. Inflation pressure of the device was set 10 mmHg lower than diastolic pressure or 70 mmHg as maximum. Pre-occlusion baseline measurements were made from each fingertip for 2 min and 10 s. Occlusion measurements were performed by the help of a cuff placed on the forearm with 200 mmHg or 60 mmHg higher than the systolic blood pressure of the patient. Pulse amplitudes were recorded, and pre-occlusion and post-occlusion ratios were compared by the software of the device, in an operator or interpreter independent way. Average pulse amplitudes for each 30 s were provided by the device software. A RHI and heart rate variability measurements were noted for each patient.

Biochemical test {#S20009}
----------------

Venous blood samples were obtained early in the morning after 12-h fasting. The following parameters were evaluated: fasting blood glucose, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglyceride, calcium, phosphorus, ionized calcium, and parathyroid hormone (PTH) levels. Parathyroid hormone levels were measured by electrochemiluminescence immunoassay (ECLIA) by an Elecsys 2010 analyser with inter-assay coefficient of variation below or equal to 6.5%. Thyroid-stimulating hormone (TSH) was measured by electrochemiluminescence immunoassay (ECLIA) using Immulite 2000 (Diagnostic Products Corp, Los Angeles, CA, USA) and Abbot Architect 2000. Fasting blood glucose, total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride, calcium, phosphorus, and ionized calcium measurements were made using an automatic colorimetric method by Cobas Integra 400 Analyzer. 25-OHD measurements were made using high performance liquid chromatography (HPLC). ALT and AST were measured by automatic colorimetric assay by Cobas Integra 400 Analyzer. All measurements were standardized and performed in central laboratories of Ufuk University Medical Faculty Biochemistry Department.

Statistical analysis {#S20010}
--------------------

A specific database was created containing all the available variables. Full descriptive statistics were calculated for each parameter. Normality distribution of continuous variables was tested by the Kolmogorov-Smirnov test. Comparisons between groups were carried out by the application of the Student *t*-test for unpaired samples or by the Mann-Whitney *U*-test. A stepwise linear regression was performed to evaluate the predictor of endothelial function. Stepwise multiple regression analysis was performed to determine the best predictors of RHI among the studied parameters.

A *p* level less than 0.05 was considered as statistically significant. All statistics were calculated with the help of the SPSS 15.0 (for MS Windows) statistical software.

Results {#S0003}
=======

The mean ± SD of the studied parameters is reported in [Table I](#T0001){ref-type="table"}. Comparing subjects with low or normal serum vitamin D level, we observed that the group with low vitamin D also had significantly lower RHI (*p* = 0.042).

###### 

Distribution of variables among normal and low 25OHD groups

  Variables                     All patients[†](#TF0001){ref-type="table-fn"} (*n* = 56)   Normal 25OHD (*n* = 23)   Low 25-OHD (*n* = 33)   Value of *p*
  ----------------------------- ---------------------------------------------------------- ------------------------- ----------------------- --------------
  Age \[years\]                 41.4 ±8.6                                                  43.0 ±8.2                 40.27 ±8.7              0.245
  BMI \[kg/m^2^\]               26.0 ±4.2                                                  26.4 ±4.1                 25.7 ±4.2               0.562
  SBP \[mmHg\]                  118.7 ±9.4                                                 119.9 ±7.6                117.8 ±10.4             0.428
  DBP \[mmHg\]                  69.0 ±6.9                                                  72.6 ±5.9                 66.4 ±6.5               0.001
  HR                            78.79 ±9.29                                                78.83 ±9.80               78.76 ±9.08             0.979
  Glucose \[mg/dl\]             91.82 ±9.67                                                93.79 ±12.48              90.44 ±7.00             0.978
  Haemoglobin \[g/dl\]          13.13 ±0.93                                                13.03 ±0.86               13.20 ±0.98             0.510
  Creatinine \[mg/dl\]          0.64 ±0.09                                                 0.64 ±0.08                0.65 ±0.10              0.722
  Albumin \[g/dl\]              4.42 ±0.23                                                 4.39 ±0.30                4.45 ±0.16              0.390
  ALT \[U/l\]                   17.52 ±9.23                                                20.26 ±11.54              15.61 ±6.76             0.063
  AST \[U/l\]                   16.77 ±7.05                                                17.09 ±9.85               16.55 ±4.28             0.780
  TSH \[mIU/ml\]                1.69 ±1.17                                                 1.84 ±0.93                1.59 ±1.32              0.450
  Total cholesterol \[mg/dl\]   193.61 ±32.40                                              196.49 ±30.42             191.60 ±34.03           0.583
  LDL-C \[mg/dl\]               116.56 ±26.81                                              118.49 ±26.67             115.22 ±27.23           0.658
  HDL-C \[mg/dl\]               54.34 ±12.38                                               54.25 ±15.85              54.41 ±9.53             0.962
  TG \[mg/dl\]                  109.24 ±17.98                                              105.53 ±18.11             111.83 ±17.70           0.200
  Calcium \[mg/dl\]             9.28 ±0.35                                                 9.25 ±0.39                9.31 ±0.32              0.536
  Ionized calcium \[mmol/l\]    1.09 ±0.03                                                 1.08 ±0.035               1.10 ±0.036             0.292
  Phosphorus \[mg/dl\]          3.42 ±0.47                                                 3.56 ±0.51                3.33 ±0.42              0.075
  25OHD \[µg/l\]                21.32 ±14.82                                               36.25 ±11.61              10.91 ±3.61             0.001
  PTH \[pg/ml\]                 49.71 ±17.80                                               44.16 ±14.64              53.57 ±18.97            0.051
  RHI                           2.29 ±0.97                                                 2.61 ±1.11                2.01 ±0.81              0.042

BMI -- body mass index, 25OHD -- 25-OH vitamin D, PTH -- parathormone, ALT -- alanine transaminase, AST -- aspartate transaminase, TSH -- thyroid stimulating hormone, TG -- triglycerides, LDL-C -- low-density lipoprotein cholesterol, HDL-C -- high-density lipoprotein cholesterol, SBP -- systolic blood pressure, DBP -- diastolic blood pressure, RHI -- reactive hyperaemia index, HR -- heart rate

^†^all parameters are given as mean ± standard deviation

Although calcium, ionized calcium and/or phosphorus levels did not show any significant difference, there was a difference in PTH levels between groups but it was not statistically significant. Diastolic blood pressure and RHI were significantly lower in the low 25-OHD group than in subjects with normal 25-OHD levels.

The stepwise multiple regression showed that the best RHI positive predictors were serum 25-OHD (β = 0.026; 95% CI 0.010--0.042, *p* = 0.002) and serum albumin (β = 1.318; 95% CI 0.286-2.350, *p* = 0.013), while the negative one was serum calcium (β = −0.678; 95% CI (−1.347)-(−0.010), *p* = 0.047) ([Figure 1](#F0001){ref-type="fig"}).

![Simple scatter plot of correlation between RHI and vitamin D levels](AMS-8-18210-g001){#F0001}

Discussion {#S0004}
==========

Since the early 1980s, the discovery of vitamin D receptors in non-classical sites (pancreas β cells, hair follicles, some cancer cells, etc) has opened a new point of view on vitamin D metabolism and its role in the body \[[@CIT0023]\]. Vitamin D and related mechanisms were well studied in chronic renal disease patients but data on normal people started to increase recently. However, beyond some interesting evidence it is not yet clear how vitamin D is related to vascular function. Recently it has been observed that the expression of proinflammatory transcription factor nuclear factor κB (NFκB) was found to be greater in vitamin D deficient middle aged and older adults: inhibition of NFκB by oral acetylsalicylic acid improved brachial artery flow-mediated dilatation especially in vitamin D deficient patients \[[@CIT0002]\]. On the other hand, chronic active vitamin D treatment could reduce the levels of reactive oxygen radicals and the expression of cyclooxygenase-1 mRNA, as well \[[@CIT0012]\]. The higher incidence of cardiovascular events in winter could also be partly related to the lower vitamin D levels in this season, since low vitamin D seems to be linked to higher serum lipid peroxidation levels and decreased brachial artery FMD on ultrasonographic measurements \[[@CIT0024]\].

In our study, the RHI ratio was significantly lower in vitamin D deficient subjects than in subjects with normal serum vitamin D, and RHI values were strictly predicted by the serum vitamin D levels. Probably the absence of other risk factors such as diabetes, kidney disease, hyperlipidaemia, hypertension or smoking state has a role in RHI measurements higher than endothelial dysfunction thresholds (1.67) even in low vitamin D subjects. The better RHI ratio in normal 25-OHD patients was also associated with a slightly but significantly lower diastolic blood pressure level in this group of normotensive women. Moreover, RHI was predicted by calcium and albumin separately, but not by ionized calcium levels. The inverse relationship between calcium level and RHI ratio is not consistent with the previous *ex-vivo* evidence obtained from a human umbilical vein cord endothelial cell culture which revealed that lower extracellular ionized calcium levels may change endothelial cell functions negatively by decreasing nitric oxide availability and increasing inflammatory mediators \[[@CIT0025]\]. The possible mechanisms of vitamin D action on endothelial functions are not totally elucidated in the medical literature, but the studies reveal that it might be related to the effects of vitamin D on the renin-angiotensin system as providing a "crosstalk" between the heart and kidneys, effects on free radical production, inflammatory and fibrotic processes, carbohydrate tolerance and endothelial progenitor cells \[[@CIT0026]--[@CIT0029]\].

Our study has some limitations. First of all, the patient sample was relatively small. Also, PAT measurements evaluate endothelium-dependent vasodilatation as a response to ischaemia, so we cannot suggest a link between 25-OHD levels and endothelium-independent vasodilatation from this study. Meanwhile, since the study groups were all women, it is not possible to extrapolate these results to all people. Another restriction was the lack of comparison between pre- and post-menopausal women, or according to BMI, because of the low patient number. Additionally, the blood pressure measurements were not 24-h ambulatory measurements, which are a more reliable method to evaluate differences in blood pressure level between groups. Furthermore, since we did not include male patients, among whom smoking is relatively common in Turkey, that may affect the PAT measurements. On the other hand, the medical literature shows that endothelial results of vitamin D deficiency do not differ between genders \[[@CIT0015], [@CIT0016]\].

However, medical studies examining the effect of vitamin D levels on endothelial dysfunction evaluated by tonometric methods are not common. Pulse amplitude tonometry measurement requires a device and software with digital sensors which are not suitable for multiple use. Therefore this method may have limited use. But the device does have the advantage of using data from both arms and it uses the other arm as a control for systemic vascular changes during measurement. Moreover, previous studies support the use of digital PAT as a measure of peripheral vasomotor function, and nitric oxide has been shown to be an important contributor to augmentation in pulse amplitude measured from the finger tip after ischaemia, supported by a blunted response in PAT in the presence of endothelial nitric oxide synthase inhibitor \[[@CIT0030]\].

In the study of Mheid *et al*. it was also shown that vitamin D replacement may also improve endothelial function and decreases mean arterial blood pressure in vitamin D insufficiency \[[@CIT0031]\]. Although this may suggest reversibility of endothelial dysfunction in vitamin D insufficiency, some points, such as the effect of the duration of insufficiency, extrapolation of these results to vitamin D deficiency, dose and type of vitamin D preparation to be used, and time to restore normal endothelial function, are still not clear.

Infact, vitamin D may have role in some mechanisms related with endothelial vasodilatation and hypertension, which are not still very clear in medical literature \[[@CIT0032]\].

In conclusion, on the basis of our study, it appears that serum 25-OHD is strongly related to endothelial functions measured from digital pulse amplitude hyperaemic response, even in healthy non-smoker women without hypertension, hyperlipidaemia, or diabetes. Further studies are needed to evaluate the potential importance of vitamin D replacement on prevention or reversal of endothelial dysfunction, and in both genders.
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